Knowledge Hub

The dermatology industry has been a hotbed of M&A activity for a decade now, driven by strong cash flow, predictable patient demand, and a balanced mix of medical and elective services. Private equity firms and strategic buyers are actively consolidating the space, targeting practices with multiple providers, ancillary revenue streams, and scalable operations. As competition increases, well-managed dermatology groups with diversified services and payer stability are commandin